CAP, NGSP focus on quality, standardization, safety
RESEARCH TRIANGLE PARK, N.C., Jan. 20 /PRNewswire/ -- Quintiles
Transnational Corp. today announced that its central laboratory operation in
China has earned two significant certifications -- one from the College of
American Pathologists (CAP) and the other from the National Glycohemoglobin
Standardization Program (NGSP).
Quintiles provides central lab services in China through an agreement with
the Peking Union Medical College Hospital (PUMCH). The accreditations apply
to the services provided by the Quintiles facility at PUMCH.
"Because of the significant interest in pharmaceutical clinical
development in China, these certifications are important for our customers,
who are seeking high quality laboratory services to support their efforts in
China," said Tom Wollman, Vice President, Quintiles Global Central
Laboratories. "Customers need local, high-quality central laboratory services
that will stand up to regulatory requirements worldwide. Now, Quintiles is
one of only two central laboratory service providers in China to receive CAP
accreditation."
CAP certification follows a site inspection. The accreditation is
intended to improve patient safety by advancing the quality of pathology and
laboratory services through education, setting standards and ensuring
laboratories meet or exceed regulatory requirements.
NGSP certification means that the lab's measurement of glycated hemoglobin
is highly precise, which is critical in providing comparable results reported
in a Diabetes Control and Complications Trial. This is especially important
to customers conducting diabetes studies in China.
"We are very honored to be certified by two organizations whose primary
concerns are quality, standardization and the safety of patients," said Alan
Ong, Vice President, Quintiles Laboratories Asia.
In addition to the Beijing facility, Quintiles' Global Central
Laboratories organization has CAP certified labs in Singapore; Atlanta, Ga.,
U.S.; Edinburgh, Scotland; and Centurion, S.A.
About Quintiles Global Central Labs
Quintiles' network of laboratories covers one of the broadest geographic
areas in the industry with owned facilities in the U.S., Europe, South Africa
and Singapore, operational offices in South America and China and sub-contract
facilities in China, Brazil, Argentina and Australia.
About Quintiles
Quintiles is the global leader in pharmaceutical services. We improve
healthcare worldwide by providing innovative, quality professional expertise,
market intelligence and partnering solutions to meet the dynamic needs of the
pharmaceutical, biotechnology and healthcare industries. Quintiles has about
16,000 specialized employees and offices in 50 countries. For more
information visit the company's Web site at http://www.quintiles.com.
SOURCE Quintiles Transnational Corp.
 back to top
Related links:
http://www.quintiles.com
CONTACT:
Dick Jones, Media Relations, +1-919-998-2091,
or media.info@quintiles.com, or Greg Connors, Investor Relations,
+1-919-998-2000, or invest@quintiles.com, both of Quintiles
Transnational Corp.
|
